Michael Gwarisa Vaccines are temperature-sensitive biological products, and even small changes in temperature during storage or transport can significantly reduce their safety and effectiveness. While all vaccines are sensitive to heat, some can also be damaged by freezing or exposure to light. To ensure potency throughout the immunisation supply chain, the World Health Organization (WHO)
Read More
Michael Gwarisa United States President Donald Trump signed into law a US$5.88 billion bipartisan spending package on February 3, 2026 that restores and expands American support for global HIV initiatives, according to a statement from the Joint United Nations Programme on HIV/AIDS (UNAIDS). The package represents one of the largest single‑year pledges of U.S. government funding for the
Read More
Michael Gwarisa African Heads of State and Government have pledged to accelerate local manufacturing of health products as part of a continent wide push to strengthen health security, reduce import dependence, and improve preparedness for future pandemics. Leaders from all 54 member states of the African Union made the commitment during high level engagements held
Read More
Michael Gwarisa Zimbabwean scientist Dr. Tariro Makadzange has been named to the TIME100 Health 2026 list by TIME, a recognition that signals the growing prominence of Africa-led clinical trials infrastructure. The list spotlights the 100 most influential leaders in health from around the world in 2026. Dr Makadzange is the founder and Chief Executive Officer
Read More
Michael Gwarisa The Zimbabwe Association of Doctors for Human Rights (ZADHR) has publicly endorsed Clause 11 of the Medical Services Amendment Bill, a provision that seeks to broaden access to safe termination of pregnancy services in Zimbabwe. Zimbabwe currently permits abortion under limited circumstances, including when a pregnancy poses a serious risk to a woman’s
Read More
By Michael Gwarisa The Democratic Republic of Congo (DRC) accounts for 68 percent of all cholera cases reported in the region in 2026, as well as 80 percent of all cholera-related deaths, the Africa Centres for Disease Control and Prevention (Africa CDC) has said. Other African countries currently experiencing active cholera outbreaks include Zimbabwe, Zambia,
Read More
By Michael Gwarisa As Zimbabwe prepares to roll out Lenacapavir, an injectable pre-exposure prophylaxis drug, anticipation is growing among people waiting for their turn. The initial consignment consists of just 2,000 doses, meaning distribution will focus on groups classified as high risk. Despite its high efficacy, Dr Owen Mugurungi, Director of AIDS, TB and Malaria
Read More
By Michael Gwarisa Minister of Health and Child Care, Dr Douglass Mombeshora, has announced that Zimbabwe now recognises eye health as an integral component of Universal Health Coverage and national development. He made the remarks while addressing a Breakfast Meeting during the recently concluded ECSA Health Community Conference in Mbabane, Eswatini. “Across the ECSA region,
Read More